These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7206588)

  • 61. Intrahepatic and intravenous administration of adriamycin--a comparative pharmacokinetic study in patients with malignant liver tumours.
    Eksborg S; Cedermark BJ; Strandler HS
    Med Oncol Tumor Pharmacother; 1985; 2(1):47-54. PubMed ID: 4058077
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat.
    Han G; Israel M; Seshadri R; Dalton JT; Sweatman TW
    Cancer Chemother Pharmacol; 1996; 37(5):472-8. PubMed ID: 8599871
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tissue distribution and antitumor effect of liposome-entrapped doxorubicin (adriamycin) in Ehrlich solid tumor-bearing mouse.
    Shinozawa S; Araki Y; Oda T
    Acta Med Okayama; 1981 Dec; 35(6):395-405. PubMed ID: 6459710
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model.
    Chan KK; Cohen JL; Gross JF; Himmelstein KJ; Bateman JR; Tsu-Lee Y; Marlis AS
    Cancer Treat Rep; 1978 Aug; 62(8):1161-71. PubMed ID: 688253
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Pharmacokinetic study of adriamycin in dogs. The problem of parameter calculations].
    Frutos G; Cadórniga R; Martín P; Bellido V
    Rev Esp Oncol; 1982; 29(2):269-81. PubMed ID: 7188230
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Method for the determination of 4'-deoxydoxorubicin, 4'-deoxydoxorubicinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography.
    Cummings J
    J Chromatogr; 1985 Jun; 341(2):401-9. PubMed ID: 4030989
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration.
    Eksborg S; Stendahl U; Lönroth U
    Eur J Clin Pharmacol; 1986; 30(5):629-31. PubMed ID: 3463510
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Quantitative determination of low concentrations of adriamycin in plasma and cell cultures, using a volatile extraction buffer.
    Van Lancker MA; Bellemans LA; De Leenheer AP
    J Chromatogr; 1986 Jan; 374(2):415-20. PubMed ID: 3457018
    [No Abstract]   [Full Text] [Related]  

  • 69. Polarographic determination of doxorubicin and daunorubicin in pharmaceutical preparations and biological media.
    Golabi SM; Nematollahi D
    J Pharm Biomed Anal; 1992; 10(10-12):1053-7. PubMed ID: 1298361
    [No Abstract]   [Full Text] [Related]  

  • 70. Comparison of efficacy, toxicity and pharmacokinetics of free adriamycin and adriamycin linked to oxidized dextran in rats.
    Ueda Y; Munechika K; Kikukawa A; Kanoh Y; Yamanouchi K; Yokoyama K
    Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1639-41. PubMed ID: 2476250
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetics of 4'-epi-doxorubicin in man.
    Weenen H; Lankelma J; Penders PG; McVie JG; ten Bokkel Huinink WW; de Planque MM; Pinedo HM
    Invest New Drugs; 1983; 1(1):59-64. PubMed ID: 6590528
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantitation of adriamycin content by a sensitive immunochemical assay.
    Citro G; Verdina A; Galati R; Floridi A
    Anticancer Res; 1988; 8(4):549-52. PubMed ID: 3178147
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quantitative analysis of the lipophilic doxorubicin analogue annamycin in plasma and tissue samples by reversed-phase chromatography.
    Zou Y; Hayman A; Priebe W; Perez-Soler R
    J Pharm Sci; 1993 Nov; 82(11):1151-4. PubMed ID: 8289131
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Simultaneous determination of free and bound adriamycin, adriamycinol, adriamycinone and duanorubicin in plasma using column-switching technique and protein-coated pre-columns.
    Emara S; Morita I; Tamura K; Razee S; Masujima T; Mohamed HA; El-Gizawy SM; El-Rabbat NA
    Talanta; 1994 Nov; 41(11):1973-80. PubMed ID: 18966158
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A resonance light-scattering off-on system for studies of the selective interaction between adriamycin and DNA.
    Chen Z; Zhang G; Chen X; Gao W
    Anal Bioanal Chem; 2012 Feb; 402(6):2163-71. PubMed ID: 22227813
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relationship between the intracellular accumulation of anthracyclines and effectiveness in vitro and in vivo.
    Tapiero H; Munck JN; Fourcade A
    Drugs Exp Clin Res; 1986; 12(1-3):257-64. PubMed ID: 3460752
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapy.
    Piazza E; Donelli MG; Broggini M; Sessa C; Natale N; Ottolenghi L; Marsoni S; Libretti A; Mangioni C; Morasca L
    Cancer Treat Rep; 1980; 64(8-9):845-54. PubMed ID: 7448822
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis and pharmacokinetics of a new prodrug N-l-leucyldoxorubicin and its metabolites in plasma using HPLC with fluorescence detection.
    de Jong J; Vermorken JB; van der Vijgh WJ
    J Pharm Biomed Anal; 1992 Apr; 10(4):309-14. PubMed ID: 1420461
    [No Abstract]   [Full Text] [Related]  

  • 79. Distribution of radioactivity and anthracycline-fluorescence in tissues of mice one hour after [14C]-labeled AD 32 administration. Evidence for tissue aglycone formation.
    Israel M; Karkowsky AM; Khetarpal VK
    Cancer Chemother Pharmacol; 1981; 6(1):25-30. PubMed ID: 6944160
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Distribution of adriamycin in the gastric cancer, gastric wall and regional lymph nodes after a regional arterial infusion].
    Suda Y; Izuno O
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1074-80. PubMed ID: 7184441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.